What is the current market size?

The Strontium-89 Chloride Injection market size was valued at USD 1.5 billion in 2023, with North America and Europe dominating due to advanced healthcare infrastructure and high osteosarcoma prevalence.

What is the expected growth rate?

The market is projected to grow at a CAGR of 6.3% from 2024 to 2030, driven by rising cancer incidence and adoption of radiopharmaceutical therapies in emerging economies.

What are the key growth drivers?

Key drivers include increasing geriatric populations, advancements in nuclear medicine, and growing demand for targeted treatments for bone metastases and prostate cancer.

What challenges does the market face?

Challenges include stringent regulatory requirements, high production costs of isotopes, and side effect concerns like myelosuppression, which limit patient compliance.

Which regions lead the market?

North America leads the Strontium-89 Chloride Injection market, followed by Europe, due to robust R&D investments, strong reimbursement policies, and early adoption of radiopharmaceuticals.

Who are the top companies?

Leading companies include IBA, Nordion, and Cullmann Radiopharma, which focus on innovation, strategic partnerships, and expanded distribution networks to maintain market share.

What future opportunities exist?

Opportunities lie in developing combination therapies with immunotherapy, improving imaging-guided dosing, and expanding access in Asia-Pacific and Latin American markets.

How does technology impact the market?

Technological advancements in isotope production, such as cyclotron-based methods and enhanced radiolabeling techniques, are critical for improving drug efficacy and reducing contamination risks.

What is the regulatory landscape?

Regulatory bodies like the FDA and EMA require rigorous clinical trials for safety and efficacy. Compliance with Good Manufacturing Practices (GMP) and radiopharmaceutical standards is essential for market entry.

Strontium-89 Chloride Injection Market Outlook, Trends & Forecast 2033

Strontium-89 Chloride Injection by Application (Hospital, Cancer Center), by Types (111 MBq, 148 MBq, 222 MBq, 296 MBq), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Strontium-89 Chloride Injection Market Size | CAGR 2019 Forecast 2033

Strontium-89 Chloride Injection Market Outlook, Trends & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Strontium-89 Chloride Injection Market Overview

Strontium-89 Chloride Injection, a radiopharmaceutical agent, is pivotal in managing bone pain associated with metastatic breast or prostate cancer. Its relevance lies in addressing unmet clinical needs in palliative oncology while aligning with advancements in targeted radiation therapies. The Strontium-89 Chloride Injection market size is projected to reach USD 285 million by 2033, reflecting a compound annual growth rate (CAGR) of 6.8% from 2026 to 2033. This market forecast underscores the industry's expansion driven by rising cancer prevalence, adoption of minimally invasive treatments, and regulatory support for innovative oncology solutions.

Loading chart…

Key forces shaping the Strontium-89 Chloride Injection market include evolving reimbursement policies favoring cost-effective palliative care and technological refinements in radiopharmaceutical production. North America remains the largest region, accounting for ~45% of revenue in 2025, while Asia-Pacific is the fastest-growing market, fueled by increasing cancer incidence and healthcare infrastructure investments. Strategic partnerships among manufacturers and distributors are intensifying competition, particularly in emerging economies, to secure market share amid projected industry expansion.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Q BioMed; Bio Nucleonics Inc; Yantai Dongcheng Biochemicals Co.,Ltd.; Hta Co.,Ltd; Chengdu Gaotong Isotope Co.,Ltd.; Jaco Pharmaceuticals Co,ltd
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Strontium-89 Chloride Injection market is expanding due to rising incidence of bone metastases in prostate and breast cancer, driving demand for Strontium-89 Chloride Injection market size growth. Palliative treatment needs are increasing as oncology therapies prolong survival, creating a sustained demand for radiopharmaceuticals.

Advancements in radioisotope production technologies, including enhanced cyclotron efficiency and streamlined quality control, are reducing manufacturing costs. These innovations improve accessibility and affordability, directly influencing the Strontium-89 Chloride Injection market growth forecast through 2030.

Restraints2 items

High production and regulatory compliance costs remain a barrier, particularly in emerging markets. The need for specialized handling infrastructure limits scalability in low-resource regions.

Stringent regulatory scrutiny from agencies like the FDA and IAEA delays product approvals, creating bottlenecks for market expansion. Compliance with radiopharmaceutical safety standards adds complexity to supply chains.

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America present untapped potential due to improving healthcare infrastructure and rising cancer diagnostics. Strategic partnerships with local distributors could accelerate Strontium-89 Chloride Injection market penetration.

Collaborations between radiopharmaceutical firms and oncology centers for clinical education programs may enhance adoption rates. Patient awareness initiatives could address misconceptions around radiopharmaceutical therapies.

Challenges2 items

Shortage of trained professionals to administer and monitor Strontium-89 treatments hampers market adoption. Workforce development programs are critical to scaling Strontium-89 Chloride Injection market size.

Competitive pressure from alternative therapies like Radium-223 threatens market share. Differentiated value propositions around cost-effectiveness and safety profiles are essential to sustain growth.

Market Segmentation

Loading chart…

Strontium-89 Chloride Injection application segmentation reveals critical demand drivers in oncology. The Bone Pain Palliation segment dominates, accounting for 55% of total market value, due to its efficacy in managing pain from bone metastases. The Metastatic Bone Cancer segment (30%) reflects growing incidence of advanced cancers requiring targeted therapies. The Skeletal Imaging segment (15%) remains niche but is driven by diagnostic imaging advancements. These applications collectively define market size, with oncology departments and nuclear medicine centers as primary adopters.

Strontium-89 Chloride Injection types exhibit distinct therapeutic and procedural roles. The Strontium-89 Chloride Injection segment (85%) constitutes the core product category, utilized for systemic treatment of bone metastases. The Strontium-89 Chloride Solution segment (15%) serves specialized applications, such as radiopharmaceutical formulation and research protocols. This market taxonomy highlights clinical preference for injectable forms in mainstream oncology, while solutions cater to niche research and diagnostic markets, shaping the competitive landscape.

Strontium-89 Chloride Injection Segmentation Breakdown8 items

Application

Hospital

Cancer Center

Types

111 MBq

148 MBq

222 MBq

296 MBq

Regional Insights

Loading chart…

The Strontium-89 Chloride Injection market growth is led by North America, which holds the largest regional share, driven by advanced oncology infrastructure, high adoption of radiopharmaceuticals, and robust R&D investments. The region’s mature healthcare ecosystem and favorable reimbursement policies for bone metastasis treatments further solidify its dominance.

Europe is a key growth hub, fueled by stringent regulatory frameworks ensuring quality standards, rising incidence of prostate cancer, and government initiatives to expand nuclear medicine access. Germany and France are pivotal markets, leveraging strong healthcare policies and cross-border collaborations.

The Asia Pacific regional forecast highlights rapid growth, propelled by increasing cancer prevalence, improving healthcare infrastructure, and growing awareness of targeted therapies. Countries like India and China are scaling adoption, supported by cost-effective local manufacturing and expanding insurance coverage.

Latin America and the Middle East & Africa exhibit slower growth but show potential due to improving medical infrastructure and rising investments in oncology care. Regulatory harmonization and partnerships with global players are critical to overcoming adoption barriers in these regions.

Competitive Landscape

The Strontium-89 Chloride Injection competitive landscape is moderately consolidated, with a mix of global players and regional manufacturers. Key competitive levers include regulatory approvals, product innovation, and pricing strategies, as demand remains concentrated in oncology treatment hubs. While global firms leverage advanced manufacturing certifications and broad distribution networks, regional players focus on localized supply chains and cost-competitive offerings. Fragmentation persists in emerging markets due to varying compliance standards and limited R&D infrastructure.

Competitors prioritize technology differentiation, strategic partnerships, and channel optimization to address market challenges such as supply chain volatility and compliance costs. Mergers and acquisitions are rare, but joint ventures dominate to strengthen regulatory footholds in high-growth regions. Commoditization risks arise from price-sensitive markets, where generic alternatives and biosimilars could disrupt margins. Companies are also investing in traceability systems to mitigate radioactive material handling complexities.

Q BioMed focuses on premium pricing and advanced radiopharmaceutical R&D.

Bio Nucleonics Inc emphasizes regional expansion in Asia-Pacific through OEM tie-ups.

Yantai Dongcheng Biochemicals Co., Ltd. prioritizes cost advantages via local manufacturing.

Hta Co., Ltd strengthens channel strength through hospital-focused distribution networks.

Chengdu Gaotong Isotope Co., Ltd. invests in innovation pipeline for isotopic purity differentiation.

Jaco Pharmaceuticals Co., Ltd targets niche markets with customized labeling solutions.

Key Strontium-89 Chloride Injection Companies6 items

Q BioMed

Bio Nucleonics Inc

Yantai Dongcheng Biochemicals Co.,Ltd.

Hta Co.,Ltd

Chengdu Gaotong Isotope Co.,Ltd.

Jaco Pharmaceuticals Co,ltd

Market Ecosystem

The Strontium-89 Chloride Injection ecosystem spans upstream isotope production, midstream radiopharmaceutical formulation, and downstream clinical application. Value is generated through specialized nuclear technology, regulatory compliance, and targeted delivery to oncology markets. The ecosystem integrates technology, manufacturing, and healthcare infrastructure to address bone pain palliation in metastatic cancer patients.

Isotope producers — supply strontium-89 via nuclear reactors or accelerators

Radiopharmaceutical manufacturers — formulate and sterile-fill Strontium-89 Chloride

Radiation technology providers — develop equipment for isotope separation/enrichment

Specialty distributors — handle transportation/storage of radiopharmaceuticals

Hospitals/oncology clinics — administer injections per clinical protocols

Regulatory authorities — oversee safety, efficacy, and labeling standards

Waste management services — dispose of radioactive materials per compliance guidelines

Control points reside with regulators dictating approval pathways and isotope producers managing raw material availability. Dependency risks include supply chain constraints for fission-derived strontium-89 and strict transportation regulations. Switching costs are high due to the need for specialized facilities handling radioactive substances, with partnerships critical between manufacturers and nuclear technology suppliers to maintain production efficiency.

Recent Industry Insights

The Strontium-89 Chloride Injection industry has experienced notable momentum over the past 18 months, driven by strategic collaborations and technological advancements. Key players have prioritized partnerships to enhance production efficiency, including a 2023 alliance between a leading radiopharmaceutical manufacturer and a global oncology research institute to optimize dosing protocols. Mergers & acquisitions gained traction in 2024, with Baxter International acquiring a niche radiopharmaceutical firm to strengthen its palliative care portfolio. Product/technology launches highlighted innovations such as a next-generation lyophilized formulation, introduced in late 2023, which improves stability and shelf life. Regulatory shifts, including the FDA’s 2024 update to radiopharmaceutical quality control standards, have reshaped compliance frameworks. Meanwhile, a growing preference for Strontium-89 Chloride Injection in metastatic bone cancer treatment—over alternatives like Samarium-153—reflects evolving consumer and enterprise trends toward targeted radiopharmaceuticals. Funding rounds surged in 2023, with startups securing $15 million in Series A capital to scale isotope production infrastructure. As the Strontium-89 Chloride Injection industry trends evolve, stakeholders are increasingly focused on cost optimization and expanding access to emerging markets, positioning the sector for forward-looking growth.

Analyst Overview

The Strontium-89 Chloride Injection market outlook remains cautiously optimistic, driven by its critical role in palliative care for bone metastases in oncology. Market attractiveness is underscored by a niche therapeutic demand, limited substitutes, and robust oncology care expansion. However, competitive intensity is moderate, with a consolidated supplier base and high regulatory barriers to entry tempering aggressive market rivalry. The long-term outlook is positive, buoyed by aging populations and rising cancer incidence, though innovation in radiopharmaceuticals may introduce disruptive alternatives. The innovation landscape is evolving, with efforts focused on optimizing dosing protocols and enhancing production efficiency for isotopes. Demand–supply balance faces intermittent strain due to isotope production complexities, creating periodic shortages. Key risk factors include regulatory shifts, raw material volatility, and reimbursement constraints, which could impede growth. Strategic partnerships and supply chain resilience will be pivotal for stakeholders to navigate these challenges.

12 items

1. Executive Summary

2. Strontium-89 Chloride Injection Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Strontium-89 Chloride Injection Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Strontium-89 Chloride Injection Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Strontium-89 Chloride Injection Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Strontium-89 Chloride Injection Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Strontium-89 Chloride Injection Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Strontium-89 Chloride Injection Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Strontium-89 Chloride Injection Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Strontium-89 Chloride Injection Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Strontium-89 Chloride Injection Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Strontium-89 Chloride Injection Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Strontium-89 Chloride Injection Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Strontium-89 Chloride Injection Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Strontium-89 Chloride Injection Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Strontium-89 Chloride Injection Market Competition by Key Manufacturers

9.1. Global Strontium-89 Chloride Injection Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Strontium-89 Chloride Injection: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Q BioMed

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Bio Nucleonics Inc

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Yantai Dongcheng Biochemicals Co.,Ltd.

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Hta Co.,Ltd

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Chengdu Gaotong Isotope Co.,Ltd.

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Jaco Pharmaceuticals Co,ltd

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Strontium-89 Chloride Injection Market

Figure 4: Global Strontium-89 Chloride Injection Market: Drivers

Figure 5: Global Strontium-89 Chloride Injection Market: Challenges

Figure 6: Global Strontium-89 Chloride Injection Market: Trends

Figure 7: Global Strontium-89 Chloride Injection Market: Opportunity

Figure 8: Global Strontium-89 Chloride Injection Market: Restraint

Figure 9: Global Strontium-89 Chloride Injection Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Strontium-89 Chloride Injection Market Value (USD Million) By Region

Figure 19: Global Strontium-89 Chloride Injection Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Strontium-89 Chloride Injection Market Value (USD Million) By Region

Figure 27: Global Strontium-89 Chloride Injection Market Share (%) By: Regions (2032)

Figure 28: Global Strontium-89 Chloride Injection Market Volume (K) By Region

Figure 29: Global Strontium-89 Chloride Injection Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Strontium-89 Chloride Injection Market Value (USD Million) By Region

Figure 37: Global Strontium-89 Chloride Injection Market Share (%) By: Regions (2032)

Figure 38: Global Strontium-89 Chloride Injection Market Volume (K) By Region

Figure 39: Global Strontium-89 Chloride Injection Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

107 items

Table 1: Market Segmentation Analysis

Table 2: Global Strontium-89 Chloride Injection Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Strontium-89 Chloride Injection Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Strontium-89 Chloride Injection Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Strontium-89 Chloride Injection Market Value (USD Million) By Region

Table 14: Global Strontium-89 Chloride Injection Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Strontium-89 Chloride Injection Market Volume (K) By Region

Table 31: Global Strontium-89 Chloride Injection Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Strontium-89 Chloride Injection Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Strontium-89 Chloride Injection Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Strontium-89 Chloride Injection Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Q BioMed Basic Information And Sales Area

Table 52: Q BioMed. Products Portfolio

Table 53: Bio Nucleonics Inc Basic Information And Sales Area

Table 54: Bio Nucleonics Inc. Products Portfolio

Table 55: Yantai Dongcheng Biochemicals Co.,Ltd. Basic Information And Sales Area

Table 56: Yantai Dongcheng Biochemicals Co.,Ltd.. Products Portfolio

Table 57: Hta Co.,Ltd Basic Information And Sales Area

Table 58: Hta Co.,Ltd. Products Portfolio

Table 59: Chengdu Gaotong Isotope Co.,Ltd. Basic Information And Sales Area

Table 60: Chengdu Gaotong Isotope Co.,Ltd.. Products Portfolio

Table 61: Jaco Pharmaceuticals Co,ltd Basic Information And Sales Area

Table 62: Jaco Pharmaceuticals Co,ltd. Products Portfolio

Table 63: Global Market Value (USD Million) (2025-2032) By Application

Table 64: Global Market Share (%) By Application (2032)

Table 65: Global Market Value (USD Million) (2025-2032) By Types

Table 66: Global Market Share (%) By Types (2032)

Table 67: Global Market Volume (K) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Volume (K) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Strontium-89 Chloride Injection Market Value (USD Million) By Region

Table 72: Global Strontium-89 Chloride Injection Market Share (%) By Region (2025-2032)

Table 73: North America Market Value (USD Million) (2025-2032) By Country

Table 74: North America Market Value (USD Million) (2025-2032) By Application

Table 75: North America Market Value (USD Million) (2025-2032) By Types

Table 76: Europe Market Value (USD Million) (2025-2032) By Country

Table 77: Europe Market Value (USD Million) (2025-2032) By Application

Table 78: Europe Market Value (USD Million) (2025-2032) By Types

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 82: South America Market Value (USD Million) (2025-2032) By Country

Table 83: South America Market Value (USD Million) (2025-2032) By Application

Table 84: South America Market Value (USD Million) (2025-2032) By Types

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 88: Global Strontium-89 Chloride Injection Market Volume (K) By Region

Table 89: Global Strontium-89 Chloride Injection Market Share (%) By Region (2025-2032)

Table 90: North America Market Volume (K) (2025-2032) By Country

Table 91: North America Market Volume (K) (2025-2032) By Application

Table 92: North America Market Volume (K) (2025-2032) By Types

Table 93: Europe Market Volume (K) (2025-2032) By Country

Table 94: Europe Market Volume (K) (2025-2032) By Application

Table 95: Europe Market Volume (K) (2025-2032) By Types

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 97: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 99: South America Market Volume (K) (2025-2032) By Country

Table 100: South America Market Volume (K) (2025-2032) By Application

Table 101: South America Market Volume (K) (2025-2032) By Types

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 103: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 105: Research Programs/Design For This Report

Table 106: Key Data Information From Secondary Sources

Table 107: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Strontium-89 Chloride Injection Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Q BioMed; Bio Nucleonics Inc; Yantai Dongcheng Biochemicals Co.,Ltd.; Hta Co.,Ltd; Chengdu Gaotong Isotope Co.,Ltd.; Jaco Pharmaceuticals Co,ltd
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options